Frequent SPAC investors Francisco Partners announced this morning that they have launched a cash tender offer to purchase 7,500,000 Pathfinder (NASDAQ:PFDR) Class A shares for $10 per share. The offer will expire on January 4, 2023, at 11:59 p.m. EST.
Francisco Partners is also to acquire a one-fifth warrant per share and holders and the move is a part of a commitment letter it signed on October 3 and equity grant agreement announced November 14. Under this agreement, Francisco Partners is to receive an additional 1,000,000 shares and Movella is to issue $25 million in senior secured notes to it.
These notes hold a 9.25% interest rate, which is to increase by 0.5% each year on the anniversary of the November 14 signing. This financing may form an important backstop as Pathfinder may need to extend its February 19, 2023 completion deadline.
Pathfinder initially announced its $537 million combination with Movella on October 4 and terminated an earlier combination agreement with ServiceMax in December 2021. San Jose, California-based Movella provides motion-capture hardware and software for the entertainment, health and manufacturing industries.
Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...